This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wardell, S. E.
Right arrow Articles by Edwards, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wardell, S. E.
Right arrow Articles by Edwards, D. P.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2002, p. 5451-5466, Vol. 22, No. 15
0270-7306/02/$04.00+0     DOI: 10.1128/MCB.22.15.5451-5466.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator

Suzanne E. Wardell,1 Viroj Boonyaratanakornkit,2 James S. Adelman,2 Ami Aronheim,3 and Dean P. Edwards1,2*

Program in Molecular Biology,1 Department of Pathology, University of Colorado Health Sciences Center, Denver, Colorado 80262,2 Department of Molecular Genetics, The B. Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel3

Received 12 November 2001/ Returned for modification 31 December 2001/ Accepted 25 April 2002

The progesterone receptor (PR) contains two transcription activation function (AF) domains, constitutive AF-1 in the N terminus and AF-2 in the C terminus. AF-2 activity is mediated by a hormone-dependent interaction with a family of steroid receptor coactivators (SRCs). SRC-1 can also stimulate AF-1 activity through a secondary domain that interacts simultaneously with the primary AF-2 interaction site. Other protein interactions and mechanisms that mediate AF-1 activity are not well defined. By interaction cloning, we identified an AP-1 family member, Jun dimerization protein 2 (JDP-2), as a novel PR-interacting protein. JDP-2 was first defined as a c-Jun interacting protein that functions as an AP-1 repressor. PR and JDP-2 interact directly in vitro through the DNA binding domain (DBD) of PR and the basic leucine zipper (bZIP) region of JDP-2. The two proteins also physically associate in mammalian cells, as detected by coimmunoprecipitation, and are recruited in vivo to a progesterone-inducible target gene promoter, as detected by a chromatin immunoprecipitation (ChIP) assay. In cell transfection assays, JDP-2 substantially increased hormone-dependent PR-mediated transactivation and worked primarily by stimulating AF-1 activity. JDP-2 is a substantially stronger coactivator of AF-1 than SRC-1 and stimulates AF-1 independent of SRC-1 pathways. The PR DBD is necessary but not sufficient for JDP-2 stimulation of PR activity; the DBD and AF-1 are required together. JDP-2 lacks an intrinsic activation domain and makes direct protein interactions with other coactivators, including CBP and p300 CBP-associated factor (pCAF), but not with SRCs. These results indicate that JDP-2 stimulates AF-1 activity by the novel mechanism of docking to the DBD and recruiting or stabilizing N-terminal PR interactions with other general coactivators. JDP-2 has preferential activity on PR among the nuclear receptors tested and is expressed in progesterone target cells and tissues, suggesting that it has a physiological role in PR function.


* Corresponding author. Mailing address: Department of Pathology, University of Colorado Health Sciences Center, Denver, CO 80262. Phone: (303) 315-5416. Fax: (303) 315-6721. E-mail: Dean.Edwards{at}uchsc.edu.


Molecular and Cellular Biology, August 2002, p. 5451-5466, Vol. 22, No. 15
0022-538X/02/$04.00+0     DOI: 10.1128/MCB.22.15.5451-5466.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Hill, K. K., Roemer, S. C., Jones, D. N. M., Churchill, M. E. A., Edwards, D. P. (2009). A Progesterone Receptor Co-activator (JDP2) Mediates Activity through Interaction with Residues in the Carboxyl-terminal Extension of the DNA Binding Domain. J. Biol. Chem. 284: 24415-24424 [Abstract] [Full Text]  
  • Rasmussen, M. H., Wang, B., Wabl, M., Nielsen, A. L., Pedersen, F. S. (2009). Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis. Nucleic Acids Res 37: 4657-4671 [Abstract] [Full Text]  
  • Xie, Y.-B., Nedumaran, B., Choi, H.-S. (2009). Molecular characterization of SMILE as a novel corepressor of nuclear receptors. Nucleic Acids Res 37: 4100-4115 [Abstract] [Full Text]  
  • Abdel-Hafiz, H., Dudevoir, M. L., Horwitz, K. B. (2009). Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation. J. Biol. Chem. 284: 9099-9108 [Abstract] [Full Text]  
  • Shatnawi, A., Tran, T., Ratnam, M. (2007). R5020 and RU486 Act as Progesterone Receptor Agonists to Enhance Sp1/Sp4-Dependent Gene Transcription by an Indirect Mechanism. Mol. Endocrinol. 21: 635-650 [Abstract] [Full Text]  
  • Buser, A. C., Gass-Handel, E. K., Wyszomierski, S. L., Doppler, W., Leonhardt, S. A., Schaack, J., Rosen, J. M., Watkin, H., Anderson, S. M., Edwards, D. P. (2007). Progesterone Receptor Repression of Prolactin/Signal Transducer and Activator of Transcription 5-Mediated Transcription of the {beta}-Casein Gene in Mammary Epithelial Cells. Mol. Endocrinol. 21: 106-125 [Abstract] [Full Text]  
  • Lu, N. Z., Wardell, S. E., Burnstein, K. L., Defranco, D., Fuller, P. J., Giguere, V., Hochberg, R. B., McKay, L., Renoir, J.-M., Weigel, N. L., Wilson, E. M., McDonnell, D. P., Cidlowski, J. A. (2006). International Union of Pharmacology. LXV. The Pharmacology and Classification of the Nuclear Receptor Superfamily: Glucocorticoid, Mineralocorticoid, Progesterone, and Androgen Receptors. Pharmacol. Rev. 58: 782-797 [Full Text]  
  • Man, J.-H., Li, H.-Y., Zhang, P.-J., Zhou, T., He, K., Pan, X., Liang, B., Li, A.-L., Zhao, J., Gong, W.-L., Jin, B.-F., Xia, Q., Yu, M., Shen, B.-F., Zhang, X.-M. (2006). PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus. Nucleic Acids Res 34: 5552-5566 [Abstract] [Full Text]  
  • Tung, L., Abdel-Hafiz, H., Shen, T., Harvell, D. M. E., Nitao, L. K., Richer, J. K., Sartorius, C. A., Takimoto, G. S., Horwitz, K. B. (2006). Progesterone Receptors (PR)-B and -A Regulate Transcription by Different Mechanisms: AF-3 Exerts Regulatory Control over Coactivator Binding to PR-B. Mol. Endocrinol. 20: 2656-2670 [Abstract] [Full Text]  
  • Huq, M. D. M., Gupta, P., Tsai, N.-P., Wei, L.-N. (2006). Modulation of Testicular Receptor 4 Activity by Mitogen-activated Protein Kinase-mediated Phosphorylation. Mol. Cell. Proteomics 5: 2072-2082 [Abstract] [Full Text]  
  • Georgiakaki, M., Chabbert-Buffet, N., Dasen, B., Meduri, G., Wenk, S., Rajhi, L., Amazit, L., Chauchereau, A., Burger, C. W., Blok, L. J., Milgrom, E., Lombes, M., Guiochon-Mantel, A., Loosfelt, H. (2006). Ligand-Controlled Interaction of Histone Acetyltransferase Binding to ORC-1 (HBO1) with the N-Terminal Transactivating Domain of Progesterone Receptor Induces Steroid Receptor Coactivator 1-Dependent Coactivation of Transcription. Mol. Endocrinol. 20: 2122-2140 [Abstract] [Full Text]  
  • Das, H., Kumar, A., Lin, Z., Patino, W. D., Hwang, P. M., Feinberg, M. W., Majumder, P. K., Jain, M. K. (2006). Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes. Proc. Natl. Acad. Sci. USA 103: 6653-6658 [Abstract] [Full Text]  
  • Poirier, M.-B., Laflamme, L., Langlois, M.-F. (2006). Identification and characterization of RanBPM, a novel coactivator of thyroid hormone receptors.. J Mol Endocrinol 36: 313-325 [Abstract] [Full Text]  
  • Wardell, S. E., Kwok, S. C., Sherman, L., Hodges, R. S., Edwards, D. P. (2005). Regulation of the Amino-Terminal Transcription Activation Domain of Progesterone Receptor by a Cofactor-Induced Protein Folding Mechanism. Mol. Cell. Biol. 25: 8792-8808 [Abstract] [Full Text]  
  • Skildum, A., Faivre, E., Lange, C. A. (2005). Progesterone Receptors Induce Cell Cycle Progression via Activation of Mitogen-Activated Protein Kinases. Mol. Endocrinol. 19: 327-339 [Abstract] [Full Text]  
  • Simmen, R. C. M., Eason, R. R., McQuown, J. R., Linz, A. L., Kang, T.-J., Chatman, L. Jr., Till, S. R., Fujii-Kuriyama, Y., Simmen, F. A., Oh, S. P. (2004). Subfertility, Uterine Hypoplasia, and Partial Progesterone Resistance in Mice Lacking the Kruppel-like Factor 9/Basic Transcription Element-binding Protein-1 (Bteb1) Gene. J. Biol. Chem. 279: 29286-29294 [Abstract] [Full Text]  
  • Obradovic, D., Tirard, M., Nemethy, Zs., Hirsch, O., Gronemeyer, H., Almeida, O. F. X. (2004). DAXX, FLASH, and FAF-1 Modulate Mineralocorticoid and Glucocorticoid Receptor-Mediated Transcription in Hippocampal Cells--Toward a Basis for the Opposite Actions Elicited by Two Nuclear Receptors?. Mol. Pharmacol. 65: 761-769 [Abstract] [Full Text]  
  • Heinrich, R., Livne, E., Ben-Izhak, O., Aronheim, A. (2004). The c-Jun Dimerization Protein 2 Inhibits Cell Transformation and Acts as a Tumor Suppressor Gene. J. Biol. Chem. 279: 5708-5715 [Abstract] [Full Text]  
  • Molenda, H. A., Kilts, C. P., Allen, R. L., Tetel, M. J. (2003). Nuclear Receptor Coactivator Function in Reproductive Physiology and Behavior. Biol. Reprod. 69: 1449-1457 [Abstract] [Full Text]  
  • Zhang, X.-L., Zhang, D., Michel, F. J., Blum, J. L., Simmen, F. A., Simmen, R. C. M. (2003). Selective Interactions of Kruppel-like Factor 9/Basic Transcription Element-binding Protein with Progesterone Receptor Isoforms A and B Determine Transcriptional Activity of Progesterone-responsive Genes in Endometrial Epithelial Cells. J. Biol. Chem. 278: 21474-21482 [Abstract] [Full Text]  
  • Hu, X., Cherbas, L., Cherbas, P. (2003). Transcription Activation by the Ecdysone Receptor (EcR/USP): Identification of Activation Functions. Mol. Endocrinol. 17: 716-731 [Abstract] [Full Text]  
  • Leonhardt, S. A., Edwards, D. P. (2002). Mechanism of Action of Progesterone Antagonists. Exp. Biol. Med. 227: 969-980 [Abstract] [Full Text]  
  • Ostrovsky, O., Bengal, E., Aronheim, A. (2002). Induction of Terminal Differentiation by the c-Jun Dimerization Protein JDP2 in C2 Myoblasts and Rhabdomyosarcoma Cells. J. Biol. Chem. 277: 40043-40054 [Abstract] [Full Text]